Decision Aid (DA) for Renal Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.
Eligibility criteria
Qualifiers
Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter.
Patients scheduled for standard-of-care clinical exams with the NYU Urology Department
Disqualifiers
Stage IV cancer of any type
Inability to provide informed consent
Vulnerable subjects will not be recruited
Trial design
Treatments tested in this trial
- Decision Aid (DA) Web Tool
- Institutional Pamphlet
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov